Zantac / Ranitidine (NDMA Cancer) Statistics in Columbus
~2.1 million
Columbus Metro Population
~200
Est. Annual Bladder Cancer Diagnoses (Franklin County)
2 years from discovery (Daubert)
OH SOL
~30,000 state employees in Columbus area
State Government Employment
Courts in Columbus, Ohio
Franklin County Court of Common Pleas
369 S High St, Columbus, OH 43215
U.S. District Court, Southern District of Ohio — Eastern Division
85 Marconi Blvd, Columbus, OH 43215
Hospitals & Trauma Centers in Columbus
The James Comprehensive Cancer Center (Ohio State University)
460 W 10th Ave, Columbus, OH 43210
OhioHealth Oncology — Riverside Methodist Hospital
3535 Olentangy River Rd, Columbus, OH 43214
Liability Considerations in Columbus
Zantac Litigation in Columbus
Columbus-area Zantac claimants have access to The James — one of the nation's premier NCI-designated cancer centers — for both treatment and documentation of cancer diagnoses. Ohio applies Daubert under Ohio R. Evid. 702. Given the federal MDL's Daubert dismissal, Columbus-area claimants should consult counsel about filing in the Delaware Superior Court, where Judge Medinilla has allowed Zantac causation experts to proceed. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.
Resources for Columbus Zantac Claimants
Columbus-area Zantac claimants should gather pharmacy records from Kroger, Giant Eagle, CVS, and Walgreens. The James Cancer Center at OSU records documenting bladder, esophageal, stomach, or colorectal cancer diagnosis, staging, and treatment are critical. Ohio's 2-year SOL applies from discovery of the diagnosis and its potential Zantac link.